At the time of discharge, insulin therapy was provided to 97% of pretransplant DM patients on outpatient insulin therapy, 92% of pretransplant DM cases who were not taking insulin and 59% of patients who did not have pretransplant DM. The gene discussed is INS; the disease is diabetes mellitus.